These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32664883)

  • 1. Smokers who have not tried alternative nicotine products: a 2019 survey of adults in Great Britain.
    Simonavicius E; McNeill A; Cheeseman H; Arnott D; Brose LS
    Harm Reduct J; 2020 Jul; 17(1):46. PubMed ID: 32664883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT.
    Hajek P; Phillips-Waller A; Przulj D; Pesola F; Smith KM; Bisal N; Li J; Parrott S; Sasieni P; Dawkins L; Ross L; Goniewicz M; Wu Q; McRobbie HJ
    Health Technol Assess; 2019 Aug; 23(43):1-82. PubMed ID: 31434605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of use of electronic cigarettes versus nicotine replacement therapy for help with smoking cessation.
    Pokhrel P; Little MA; Fagan P; Kawamoto CT; Herzog TA
    Addict Behav; 2014 Dec; 39(12):1869-73. PubMed ID: 25129173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm perceptions of e-cigarettes and other nicotine products in a UK sample.
    Wilson S; Partos T; McNeill A; Brose LS
    Addiction; 2019 May; 114(5):879-888. PubMed ID: 30609154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expenditure on smoking and alternative nicotine delivery products: a population survey in England.
    Jackson SE; Shahab L; Kock L; West R; Brown J
    Addiction; 2019 Nov; 114(11):2026-2036. PubMed ID: 31243842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harm perceptions of nicotine-containing products and associated sources of information in UK adults with and without mental ill health: A cross-sectional survey.
    Perman-Howe PR; Horton M; Robson D; McDermott MS; McNeill A; Brose LS
    Addiction; 2022 Mar; 117(3):715-729. PubMed ID: 34338387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitions in smoking and nicotine use from 2016 to 2017 among a UK cohort of adult smokers and ex-smokers.
    Simonavicius E; McNeill A; Brose LS
    Drug Alcohol Rev; 2020 Nov; 39(7):994-1005. PubMed ID: 32458503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study.
    Brown J; Beard E; Kotz D; Michie S; West R
    Addiction; 2014 Sep; 109(9):1531-40. PubMed ID: 24846453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inequalities, harm reduction and non-combustible nicotine products: a meta-ethnography of qualitative evidence.
    Lucherini M; Hill S; Smith K
    BMC Public Health; 2020 Jun; 20(1):943. PubMed ID: 32539788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cigarettes Associated With Depressed Smoking Cessation: A Cross-sectional Study of 28 European Union Countries.
    Kulik MC; Lisha NE; Glantz SA
    Am J Prev Med; 2018 Apr; 54(4):603-609. PubMed ID: 29449132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge about E-Cigarettes and Tobacco Harm Reduction among Public Health Residents in Europe.
    Ferrara P; Shantikumar S; Cabral Veríssimo V; Ruiz-Montero R; Masuet-Aumatell C; Ramon-Torrell JM;
    Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31212756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and correlates of long-term e-cigarette and nicotine replacement therapy use: a prospective study in England.
    Jackson SE; Hill E; Shahab L; Beard E; Michie S; Brown J
    BMJ Open; 2019 Oct; 9(10):e029252. PubMed ID: 31604784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Clinical Trial Examining the Effects of Instructions for Electronic Cigarette Use on Smoking-Related Behaviors and Biomarkers of Exposure.
    Hatsukami DK; Meier E; Lindgren BR; Anderson A; Reisinger SA; Norton KJ; Strayer L; Jensen JA; Dick L; Murphy SE; Carmella SG; Tang MK; Chen M; Hecht SS; O'connor RJ; Shields PG
    Nicotine Tob Res; 2020 Aug; 22(9):1524-1532. PubMed ID: 31828315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco smoking and nicotine delivery alternatives: patterns of product use and perceptions in 13 countries.
    Riahi F; Rajkumar S; Yach D
    F1000Res; 2019; 8():80. PubMed ID: 31131094
    [No Abstract]   [Full Text] [Related]  

  • 15. Electronic Cigarettes in Germany: Patterns of Use and Perceived Health Improvement.
    Lehmann K; Kuhn S; Reimer J
    Eur Addict Res; 2017; 23(3):136-147. PubMed ID: 28618425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative tobacco product use and smoking cessation: a national study.
    Popova L; Ling PM
    Am J Public Health; 2013 May; 103(5):923-30. PubMed ID: 23488521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QuitNic: A Pilot Randomized Controlled Trial Comparing Nicotine Vaping Products With Nicotine Replacement Therapy for Smoking Cessation Following Residential Detoxification.
    Bonevski B; Manning V; Wynne O; Gartner C; Borland R; Baker AL; Segan CJ; Skelton E; Moore L; Bathish R; Chiu S; Guillaumier A; Lubman DI
    Nicotine Tob Res; 2021 Feb; 23(3):462-470. PubMed ID: 32770246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Impact of Long-term Use of Nicotine Replacement Therapy in UK Stop-Smoking Services: Findings From the ELONS Study.
    Shahab L; Dobbie F; Hiscock R; McNeill A; Bauld L
    Nicotine Tob Res; 2017 Dec; 20(1):81-88. PubMed ID: 27664995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of ever regular use of non-combustible nicotine for 1 year or more: a population survey in England.
    Cox S; Brown J; Kock L; Shahab L
    Harm Reduct J; 2021 Nov; 18(1):114. PubMed ID: 34789264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes towards a hypothetical 'clean nicotine' product and harm reduction among smokers.
    Morphett K; Puljević C; Borland R; Carter A; Hall W; Gartner C
    Int J Drug Policy; 2021 Feb; 88():103020. PubMed ID: 33161296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.